Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study

Authors :: Steven G. DuBois
John Han-Chih Chang
Joseph Panoff
Stephan A. Grupp
Julie R. Park
Sheena C. Tenney
Michael D. Hogarty
Meaghan Granger
Rochelle Bagatell
Shahab Asgharzadeh
Arlene Naranjo
Gregory A. Yanik
Julie M. Gastier-Foster
Jeannine S. McCune
Brian Weiss
Denise Mills
Source :: Journal of Clinical Oncology. 34:10528-10528
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 10528Background: The COG conducted a groupwide study of a Busulfan/Melphalan (BuMel) myeloablative regimen in patients with newly diagnosed, high-risk neuroblastoma (ANBL12P1). Previously used in S...

Full Text Access

Tools